Diabetes, Vol 40, Issue 5 583-589, Copyright © 1991 by American Diabetes Association

ARTICLES

Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance

P Fasching, K Ratheiser, W Waldhausl, M Rohac, W Osterrode, P Nowotny and H Vierhapper
First Medical Department, University of Vienna, Austria.

To determine the impact of fish-oil supplementation on glucose and lipid metabolism in patients with impaired glucose tolerance (IGT), 30 ml fish oil containing 3.8 g eicosapentaenoic acid (EPA; 20:5 omega 3) and 2.5 g docosahexaenoic acid (DHA; 22:5 omega 3) were given to eight obese subjects with IGT (mean +/- SD age 50.3 +/- 8.0 yr) in addition to their regular diet for 2 wk. Studies were performed in randomized order versus an isocaloric control period with a washout phase of 3 wk. Hyperinsulinemic clamp examinations (1 and 10 mU.kg-1.min-1) were performed. Glucose disposal rate (M value) rose from basal 14.3 +/- 5.1 to 17.9 +/- 4.4 mumol.kg-1.min-1 after fish oil (P less than 0.001) during the 1-mU clamp, whereas no change was seen during the 10-mU clamp (without fish oil, 42.2 +/- 8.9 mumol.kg-1.min-1; with fish oil, 45.1 +/- 9.8 mumol.kg-1.min-1;NS). Basal hepatic glucose output remained unaffected by fish oil, whereas fractional glucose clearance after intravenous glucose loading (2.4 mmol/kg body wt, t = 30 min) tended to increase (K value: without fish oil, 2.15 +/- 1.02%/min; with fish oil, 2.74 +/- 1.26%/min; NS). Neither the fasting concentrations of glucose and insulin nor induced glycemia and insulin response during intravenous glucose loading calculated as incremental area under the curve changed after fish-oil supplementation.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. A Lovegrove, S. S Lovegrove, S. V. Lesauvage, L. M Brady, N. Saini, A. M Minihane, and C. M Williams Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians Am. J. Clinical Nutrition, June 1, 2004; 79(6): 974 - 982. [Abstract] [Full Text] [PDF]

				L. M Brady, S. S Lovegrove, S. V. Lesauvage, B. A Gower, A.-M. Minihane, C. M Williams, and J. A Lovegrove Increased n-6 polyunsaturated fatty acids do not attenuate the effects of long-chain n-3 polyunsaturated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians Am. J. Clinical Nutrition, June 1, 2004; 79(6): 983 - 991. [Abstract] [Full Text] [PDF]

				P. J. Nestel, S. E. Pomeroy, T. Sasahara, T. Yamashita, Y. L. Liang, A. M. Dart, G. L. Jennings, M. Abbey, and J. D. Cameron Arterial Compliance in Obese Subjects Is Improved With Dietary Plant n-3 Fatty Acid From Flaxseed Oil Despite Increased LDL Oxidizability Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1163 - 1170. [Abstract] [Full Text]

				I. Toft, K. H. Bonaa, O. C. Ingebretsen, A. Nordoy, and T. Jenssen Effects of n-3 Polyunsaturated Fatty Acids on Glucose Homeostasis and Blood Pressure in Essential Hypertension: A Randomized, Controlled Trial Ann Intern Med, December 15, 1995; 123(12): 911 - 918. [Abstract] [Full Text]